A blind, randomized clinical trial for puerperal infection and neonatal outcome by appropriate antiseptic agents in vaginal delivery for pregnant women and newborns

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0007038

Enrollment

4140

Registered

2022-02-24

Start date

2022-02-16

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : 1. Povidone-iodine 10%/1L - Manufacturer: Person Co., Ltd. - character : brownish liquid - Efficacy : Sterilization of lacerations, burns, cuts, sterilization of ulcers, abscesses, sterilizatio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 19 years of old or older 2) Korean singletone pregnant women 3) Plannig vaginal delivery 4) Planning delivery after gestational age 37 weeks

Exclusion criteria

Exclusion criteria: 1) Hyper-reaction to chlorhexidine-alcohol 2) Hyper-reaction to iodine or shellfish 3) Hyper-reaction to alcohol 4) Pregnant women who already with perineal skin infection

Design outcomes

Secondary

Measure	Time frame
Admission duration, clinic visit for episiotomy site problem, re-admission for episiotomy site problem, Endometritis;Neonatal prognosis	—

Primary

Measure	Time frame
Perineal episiotomy site infection	—

Countries

Korea, Republic of

Contacts

Public ContactSo hee Kim

Seoul National University Hospital

74766@snuh.org+82-2-2072-3085

Outcome results